BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15197964)

  • 1. [Apheresis treatment for fulminant hepatitis].
    Tateishi Y; Hirasawa H; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():462-6. PubMed ID: 15197964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liver failure].
    Yoshiba M
    Nihon Rinsho; 2004 May; 62 Suppl 5():545-9. PubMed ID: 15197981
    [No Abstract]   [Full Text] [Related]  

  • 3. [Blood purification for patients with chronic renal failure accompanied by severe liver disease].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():66-9. PubMed ID: 15250270
    [No Abstract]   [Full Text] [Related]  

  • 4. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.
    Nagata Y; Uto H; Hasuike S; Ido A; Hayashi K; Eto T; Hamakawa T; Tanaka K; Tsubouchi H
    Intern Med; 2003 Oct; 42(10):967-70. PubMed ID: 14606709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The evaluation for principles and clinical application of combined artificial liver therapy].
    GUO LM
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):326-7. PubMed ID: 19497192
    [No Abstract]   [Full Text] [Related]  

  • 6. Artificial liver support system in China: a review over the last 30 years.
    Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
    Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged artificial liver support in a child with fulminant hepatic failure.
    Okamoto K; Kurose M; Ikuta Y; Ogata K; Harada T; Takeda K; Sato T
    ASAIO J; 1996; 42(3):233-5. PubMed ID: 8725697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantation.
    Masuhara M; Yagawa T; Aoyagi M; Suzuki C; Sakaguchi E; Segawa M; Hironaka K; Kayano K; Tamura F; Seguchi M; Soejima Y; Murakami F; Sakaida I; Tateishi A; Fukumoto Y; Okita K
    J Gastroenterol; 2001 May; 36(5):350-3. PubMed ID: 11388400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial liver support system for fulminant hepatic failure as bridge-use to living donor liver transplantation.
    Ichida T
    Intern Med; 2003 Oct; 42(10):920-1. PubMed ID: 14606698
    [No Abstract]   [Full Text] [Related]  

  • 10. Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
    Inoue K; Kourin A; Watanabe T; Yamada M; Yoshiba M
    Transplant Proc; 2009; 41(1):259-61. PubMed ID: 19249529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change of blood parameters in liver failure patients with severe hepatitis after combined therapy].
    Lin JH; Guo YX; Zhou XH; Chen FS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Feb; 15(2):103-5. PubMed ID: 12857471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of blood purification technique in artificial liver support therapy].
    Guo LM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):43. PubMed ID: 12546745
    [No Abstract]   [Full Text] [Related]  

  • 13. [Individualized artificial liver treatment on patients with liver failure].
    DUAN ZP; ZHANG J
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):324-5. PubMed ID: 19497191
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined twice-daily plasma exchange and continuous veno-venous hemodiafiltration for bridging severe acute liver failure.
    Biancofiore G; Bindi LM; Urbani L; Catalano G; Mazzoni A; Scatena F; Mosca F; Filipponi F
    Transplant Proc; 2003 Dec; 35(8):3011-4. PubMed ID: 14697964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of plasmapheresis for hepatic disorders.
    Hida M; Watanabe J; Tanaka K; Kitamura M; Iida T; Hiraga S; Satoh T; Tanaka S; Kawamura Y; Tanaka M
    Tokai J Exp Clin Med; 1992 Dec; 17(5-6):223-7. PubMed ID: 1343429
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coping with shortage of plasma and albumin: a strategy for artificial liver].
    HUANG JR; YUAN WX
    Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):330-1. PubMed ID: 19497194
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score].
    Sun LH; Zhang YX; Xiao L; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):632, 635. PubMed ID: 16093004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of plasma exchange combined with fetal hepacyties on viral hepatitis gravis].
    Zheng XH; Tang XP; Chen J
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):437-9. PubMed ID: 12536493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Adiponectin Levels in Acute Liver Failure Patients Treated with Plasma Filtration with Dialysis and Plasma Exchange.
    Yamamoto H; Nakae H; Uji Y; Maeda K; Tani T; Eguchi Y
    Ther Apher Dial; 2015 Aug; 19(4):349-54. PubMed ID: 26386223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Organ replacement therapy - extracorporeal liver assist devices].
    Sinner B; Kirchner GI
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):554-62. PubMed ID: 27631450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.